Citation

Wheelan N, Kenyon CJ, Harris AP, Cairns C, Al Dujaili E, Seckl JR, Yau JLW. Psychoneuroendocrinology 2017; 89: 13-22.

Affiliation

Centre for Cardiovascular Science, University of Edinburgh, EH16 4TJ, United Kingdom; Centre for Cognitive Aging and Cognitive Epidemiology, University of Edinburgh, EH8 8JZ, United Kingdom. Electronic address: joyce.yau@ed.ac.uk.

Copyright

(Copyright © 2017, Elsevier Publishing)

DOI

10.1016/j.psyneuen.2017.12.018

PMID

29306773

Abstract

Chronic exposure to stress during midlife associates with subsequent age-related cognitive decline and may increase the vulnerability to develop psychiatric conditions. Increased hypothalamic-pituitary-adrenal (HPA) axis activity has been implicated in pathogenesis though any causative role for glucocorticoids is unestablished. This study investigated the contribution of local glucocorticoid regeneration by the intracellular enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), in persisting midlife stress-induced behavioral effects in mice. Middle-aged (10 months old) 11β-HSD1-deficient mice and wild-type congenic controls were randomly assigned to 28 days of chronic unpredictable stress or left undisturbed (non-stressed). All mice underwent behavioral testing at the end of the stress/non-stress period and again 6-7 months later. Chronic stress impaired spatial memory in middle-aged wild-type mice. The effects, involving a wide spectrum of behavioral modalities, persisted for 6-7 months after cessation of stress into early senescence. Enduring effects after midlife stress included impaired spatial memory, enhanced contextual fear memory, impaired fear extinction, heightened anxiety, depressive-like behavior, as well as reduced hippocampal glucocorticoid receptor mRNA expression. In contrast, 11β-HSD1 deficient mice resisted both immediate and enduring effects of chronic stress, despite similar stress-induced increases in systemic glucocorticoid activity during midlife stress. In conclusion, chronic stress in midlife exerts persisting effects leading to cognitive and affective dysfunction in old age via mechanisms that depend, at least in part, on brain glucocorticoids generated locally by 11β-HSD1. This finding supports selective 11β-HSD1 inhibition as a novel therapeutic target to ameliorate the long-term consequences of stress-related psychiatric disorders in midlife.

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Language: en

Keywords

11β-HSD1; Aging; Anxiety; Fear conditioning; Glucocorticoids; Stress